Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to explore and describe the disease characteristics, treatment and outcomes of participants with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, Crohn's Disease or ulcerative colitis as the major disease treated with REMICADE, SIMPONI or STELARA in clinical practice in the emerging regions of North Africa, the Middle East, and Western Asia.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT03006198
Study type Observational
Source Janssen Pharmaceutica N.V., Belgium
Status Completed
Start date February 4, 2016
Completion date December 1, 2018